Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer [Phase 3]
Phase 3 trial evaluating TAS-102 (trifluridine/tipiracil) plus best supportive care vs placebo plus BSC in patients with refractory metastat…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer [Phase 2]
Phase 2 trial evaluating efficacy and safety of FOLFIRI in patients 70 years and older with gastric cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer [Phase 2]
Phase 2 trial update on peri-operative sintilimab combined with SOX chemotherapy for locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy [Phase 4]
Phase 4 trial evaluating apatinib plus chemotherapy versus chemotherapy in second-line gastric cancer after prior anti-PD-1 therapy; status …
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating Sintilimab plus chemoradiotherapy followed by D2 gastrectomy in advanced gastric cancer with retroperito…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating alpelisib with paclitaxel in PIK3CA-altered gastric cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC [Phase 2]
Phase 2 trial evaluating tislelizumab with S-1 and oxaliplatin as neoadjuvant therapy for advanced gastric cancer and advanced gastroesophag…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating adjuvant chemotherapy with or without PD-1 inhibitors and chemoradiotherapy in resected pN3 gastric or G…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis [Phase 3]
Phase 3 trial update on cytoreductive surgery with or without HIPEC for gastric cancer with peritoneal carcinomatosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer [Phase 3]
Phase 3 trial comparing FLOT versus SOX as neoadjuvant chemotherapy for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer [Phase 3]
Phase 3 trial update evaluating a triplet cytotoxic combination as first-line therapy for metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient [Phase 3]
Phase 3 clinical trial comparing deep neuromuscular block in gastric cancer patients with obesity has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intraperitoneal paclitaxel with XELOX in gastric cancer with peritoneal metastasis; current status not disclose…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma [Phase 2]
Phase 2 trial update evaluating camrelizumab in combination with apatinib for advanced gastric/GEJ adenocarcinoma.
-
FDA approval · 2021-07-01FDA Approved: DOCETAXEL — Original Application (Gland Pharma Limited)
FDA approves Gland Pharma Limited's generic docetaxel as an Original Application, adding a new generic option for cancer chemotherapy.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer [Phase 2]
Phase II study investigating carelizumab with irinotecan and apatinib as second-line therapy for advanced gastric cancer is ongoing with unk…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial update on laparoscopic HIPEC for metastatic gastric cancer completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO Overexpression [Phase 2]
Phase 2 trial update of vismodegib in advanced gastric adenocarcinoma with SMO overexpression completed.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma [Phase 3]
A Phase 3 trial evaluating docetaxel versus oxaliplatin added to S-1 for stage II/III gastric adenocarcinoma; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) [Phase 2]
Phase 2 clinical trial evaluating a multi-modal intervention care for cachexia in advanced cancer versus conventional management (MIRACLE). …
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study) [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating ramucirumab, trastuzumab, and paclitaxel in HER2-positive recurrent/metastatic gastric cancer is under…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer [Phase 3]
Phase 3 study evaluating BBI608 plus weekly paclitaxel for gastric and gastroesophageal junction cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC [Phase 2]
Phase 2 trial comparing POF, FOLFOX, and FOLFOX plus paclitaxel in advanced gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies [Phase 4]
Phase 4 clinical trial comparing different bismuth quadruple therapies for Helicobacter pylori eradication in the context of gastric cancer …